If you have been on a GLP-1 for years and have lost weight, your prescriber attests to your BMI at the time you started therapy, not your current BMI
Drug Company Description Current Phase Mechanism SMALL MOLECULES Orforglipron Eli Lilly First oral small molecule GLP-1 receptor agonist with no food/water restrictions
This is a fundamentally different product from the fresh, early-harvest, high-polyphenol oils used in clinical research
Retatrutide Dosage in Clinical Trials The primary source of dosage data for retatrutide comes from the Phase 2 clinical trial published in the New England Journal of Medicine (Jastreboff et al., 2023)
(2003) Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin
Description GLOW GHK-Cu (70mg)/TB-500 (10mg)/BPC-157 (10mg) Blend Peptide 90mg Vial **Important Information: Each peptide comes lyophilized/freeze-dried and must be reconstituted with Bacteriostatic Water in order to be dispensable in liquid form
